In this week’s post EU exit corner, we bring you the latest guidance updates and publications relevant in the post EU exit environment. The most recent Trader Support Service bulletin is also available as is the latest Brexit and Beyond newsletter from the Northern Ireland Assembly EU Affairs team. And finally, we remind you that from 1 January 2025, the Windsor Framework (WF) introduces new rules in the UK for product licensing and labelling.
WF changes from 1 January 2025
From 1 January 2025, the WF introduces new rules in the UK for product licensing, labelling, and the EU Falsified Medicines Directive (FMD). This is designed to ensure that medicines can be approved and licensed on a UK-wide basis by the Medicines and Healthcare products Regulatory Agency (MHRA) and medicines can be supplied in the same packs across the UK. It also provides for the disapplication of FMD safety features for medicines marketed and supplied in Northern Ireland. Further information is available in the guidance here on the MHRA Windsor Framework Hub.
Miscellaneous guidance updates and publications